Speaker illustration

Doctor Kathy Stein

Novartis Pharma GmbH, Nuremberg (Germany)

Different perspectives of patients and physicians on LDL-C target achievement in the treatment of hypercholesterolemia: results on secondary prevention from the German PROCYON survey

Event: ESC Congress 2021 - The Digital Experience

Topic: Secondary Prevention

Session: Risk Factors and Prevention ePosters

Thumbnail

This platform is supported by

logo Novo Nordisk